Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48 USD | -2.87% | +1.69% | +34.91% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.91% | 3.79B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+47.02% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Correction: Crinetics Pharmaceuticals Says Phase 3 Trial for Acromegaly Treatment Meets Endpoints; Shares Rise Pre-Bell